Sign up to save your podcasts
Or
Share First ever CRISPR gene therapy approval: What happens next?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
First ever CRISPR gene therapy approval: What happens next?
Last Thursday, the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) approved CRISPR/Cas9 gene-edited therapy exagamglogene autotemcel (exa-cel). Will the FDA follow suit? What can patients expect the price tag to be?
Plus, a good handful of approvals for AstraZeneca, Pfizer and Astellas' Xtandi, and Keytruda.
Join BioSpace's Lori Ellis, Greg Slabodkin and Heather McKenzie as they discuss the news this week.
View all episodes
By BioSpace
4.9
1313 ratings
Last Thursday, the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) approved CRISPR/Cas9 gene-edited therapy exagamglogene autotemcel (exa-cel). Will the FDA follow suit? What can patients expect the price tag to be?
Plus, a good handful of approvals for AstraZeneca, Pfizer and Astellas' Xtandi, and Keytruda.
Join BioSpace's Lori Ellis, Greg Slabodkin and Heather McKenzie as they discuss the news this week.
More shows like BioSpace
View all
This American Life
90,841 Listeners
Planet Money
30,814 Listeners
Hidden Brain
43,719 Listeners
Marketplace
8,760 Listeners
Exchanges
954 Listeners
WSJ What’s News
4,362 Listeners
Bloomberg Surveillance
1,176 Listeners
Odd Lots
1,971 Listeners
Up First from NPR
56,879 Listeners
The Indicator from Planet Money
9,572 Listeners
The Readout Loud
323 Listeners
The Journal.
6,072 Listeners
Short Wave
6,564 Listeners
BioCentury This Week
34 Listeners
Biotech Hangout
21 Listeners